Back to Search
Start Over
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
- Source :
- Digital.CSIC. Repositorio Institucional del CSIC, instname
- Publication Year :
- 2014
-
Abstract
- We assessed the prognostic value of minimal residual disease (MRD) detection in multiple myeloma(MM) patients using a sequencing-based platform in bone marrow samples from 133 MM patients in at least very good partial response (VGPR) after front-line therapy. Deep sequencing was carried out in patients in whom a high-frequency myeloma clone was identified and MRD was assessed using the IGH-VDJH, IGH-DJH, and IGK assays. The results were contrasted with those of multiparametric flow cytometry (MFC) and allelespecific oligonucleotide polymerase chain reaction (ASO-PCR). The applicability of deep sequencing was 91%. Concordance between sequencing and MFC and ASO-PCR was 83% and 85%, respectively. Patients who were MRD- by sequencing had a significantly longer time to tumor progression (TTP) (median 80 vs 31 months; P<br />This research project was supported by grants PS09/01370, PS09/1450, PI12/01761, and PI12/023121 from the Fondo de Investigaciones Sanitarias; RD12/10 Red de Cáncer (Cancer Network of Excellence) from the Instituto de Salud Carlos III, Spain, and from the Fondo de Investigaciones Sanitarias, Asociación Española Contra el Cáncer (AECC, GCB120981SAN) and the CRIS foundation. This study was supported in part by research funding from Sequenta, Inc. (F.P., L.W., M.M., M.F.).
- Subjects :
- Adult
Male
medicine.medical_specialty
Pathology
Neoplasm, Residual
Concordance
Immunology
Plenary Paper
Biochemistry
Gastroenterology
Deep sequencing
Cohort Studies
Bone Marrow
Oligonucleotide polymerase
Internal medicine
hemic and lymphatic diseases
medicine
Humans
In patient
heterocyclic compounds
Multiple myeloma
Aged
Very Good Partial Response
Aged, 80 and over
business.industry
High-Throughput Nucleotide Sequencing
Cell Biology
Hematology
respiratory system
Middle Aged
medicine.disease
Prognosis
Minimal residual disease
body regions
medicine.anatomical_structure
Female
Bone marrow
business
Multiple Myeloma
therapeutics
Subjects
Details
- ISSN :
- 15280020
- Volume :
- 123
- Issue :
- 20
- Database :
- OpenAIRE
- Journal :
- Blood
- Accession number :
- edsair.doi.dedup.....b44ed9a751aeb682de773627704472e7